The MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease brand, founded in 2013 (United States), from 126 sister brands and 17477 competing brands. The MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease brand is owned by Celgene, a company listed in New York. MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease is part of the Drug Manufacturers activity sector.

MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease is a brand of Celgene () Share price

International deposit : 2013 Business sector Drug Manufacturers

Share price and profitability of the share Celgene (MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)

Buy Celgene share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Celgene (MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Celgene

JUNO THERAPEUTICS
JUNO THERAPEUTICS
CELGENE
CELGENE
See more brands of Celgene

Rival brands
MAPP Multinational Assessment of Psoriasis and Psoriatic Arthritis Navigating the Course of Psoriatic Disease

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS